BiotechTV - News

Pareto Securities Healthcare Conference: Egetis Therapeutics has a therapy for a rare disease called MCT8 deficiency that is approved by the EMA and has breakthrough therapy designation in the U.S.


Listen Later

CEO Nicklas Westerholm walks us through the condition, which is an X-chromosome linked rare disease that affects men, and he describes how the launch is going in Europe, and plans for an FDA meeting.

...more
View all episodesView all episodes
Download on the App Store

BiotechTV - NewsBy BiotechTV

  • 5
  • 5
  • 5
  • 5
  • 5

5

4 ratings


More shows like BiotechTV - News

View all
Planet Money by NPR

Planet Money

30,626 Listeners

Odd Lots by Bloomberg

Odd Lots

1,863 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,085 Listeners

The Readout Loud by STAT

The Readout Loud

325 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,059 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

60 Listeners

All-In with Chamath, Jason, Sacks  Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks Friedberg

9,840 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

86 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

19 Listeners

ACQ2 by Acquired by Ben Gilbert and David Rosenthal

ACQ2 by Acquired

260 Listeners

BG2Pod with Brad Gerstner and Bill Gurley by BG2Pod

BG2Pod with Brad Gerstner and Bill Gurley

497 Listeners

The Studio at Kendall Square by BiotechTV

The Studio at Kendall Square

0 Listeners

Off-Target Effects with Matt Gline by BiotechTV

Off-Target Effects with Matt Gline

4 Listeners

Biotech CEO Sisterhood by BiotechTV

Biotech CEO Sisterhood

2 Listeners

BioVenture VoiCes with Chris Garabedian by BiotechTV

BioVenture VoiCes with Chris Garabedian

6 Listeners